nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abelmoschus manihot polysaccharide fortifies intestinal mucus barrier to alleviate intestinal inflammation by modulating Akkermansia muciniphila abundance
|
Wang, Yumeng |
|
|
14 |
9 |
p. 3901-3915 |
artikel |
2 |
Advancing cancer nanomedicine with machine learning
|
Qin, Xifeng |
|
|
14 |
9 |
p. 4183-4185 |
artikel |
3 |
Allosteric regulation of Keap1 by 8β-hydroxy-α-cyclocostunolide for the treatment of acute lung injury
|
Zhang, Juan |
|
|
14 |
9 |
p. 4174-4178 |
artikel |
4 |
Aloe emodin promotes mucosal healing by modifying the differentiation fate of enteroendocrine cells via regulating cellular free fatty acid sensitivity
|
Bao, Weilian |
|
|
14 |
9 |
p. 3964-3982 |
artikel |
5 |
An iron-based metal-organic framework nanoplatform for enhanced ferroptosis and oridonin delivery as a comprehensive antitumor strategy
|
Cai, Mengru |
|
|
14 |
9 |
p. 4073-4086 |
artikel |
6 |
Author correction to “Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits” [Acta Pharm Sin B 14 (2024) 2732–2747]
|
Xiao, Bo |
|
|
14 |
9 |
p. 4193 |
artikel |
7 |
Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing
|
Fu, Wenkang |
|
|
14 |
9 |
p. 3931-3948 |
artikel |
8 |
Cover Story
|
|
|
|
14 |
9 |
p. xii |
artikel |
9 |
CRISPR-Cas9 gene editing strengthens cuproptosis/chemodynamic/ferroptosis synergistic cancer therapy
|
Wu, Xiaoyu |
|
|
14 |
9 |
p. 4059-4072 |
artikel |
10 |
Current status and trends in small nucleic acid drug development: Leading the future
|
Miao, Yuxi |
|
|
14 |
9 |
p. 3802-3817 |
artikel |
11 |
Decoding the chromatin accessibility in Andrographis paniculata genome, a case study of genome-wide investigation of the cis-regulatory elements in medicinal plants
|
Huang, Mingkun |
|
|
14 |
9 |
p. 4179-4182 |
artikel |
12 |
Discovery and evaluation of a novel 18F-labeled vasopressin 1a receptor PET ligand with peripheral binding specificity
|
Hu, Junqi |
|
|
14 |
9 |
p. 4014-4027 |
artikel |
13 |
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
|
Chen, Yunna |
|
|
14 |
9 |
p. 3834-3854 |
artikel |
14 |
Establishing cell suitability for high-level production of licorice triterpenoids in yeast
|
Sun, Wentao |
|
|
14 |
9 |
p. 4134-4148 |
artikel |
15 |
Glycodiversification of gentamicins through in vivo glycosyltransferase swapping enabled the creation of novel hybrid aminoglycoside antibiotics with potent activity and low ototoxicity
|
Jian, Xinyun |
|
|
14 |
9 |
p. 4149-4163 |
artikel |
16 |
Heme oxygenase 1-mediated ferroptosis in Kupffer cells initiates liver injury during heat stroke
|
Li, Ru |
|
|
14 |
9 |
p. 3983-4000 |
artikel |
17 |
Icaritin inhibits the progression of urothelial cancer by suppressing PADI2-mediated neutrophil infiltration and neutrophil extracellular trap formation
|
Mou, Zezhong |
|
|
14 |
9 |
p. 3916-3930 |
artikel |
18 |
Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics
|
Chan, Chris Chun-Yiu |
|
|
14 |
9 |
p. 4028-4044 |
artikel |
19 |
Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges
|
Zhang, Xiaokun |
|
|
14 |
9 |
p. 3818-3833 |
artikel |
20 |
I n situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases
|
Li, Yuan |
|
|
14 |
9 |
p. 4102-4117 |
artikel |
21 |
Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice
|
Yang, Mianling |
|
|
14 |
9 |
p. 4189-4192 |
artikel |
22 |
Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy
|
Zhou, Zaigang |
|
|
14 |
9 |
p. 4087-4101 |
artikel |
23 |
Molecular glue triggers degradation of PHGDH by enhancing the interaction between DDB1 and PHGDH
|
Huang, Ziqi |
|
|
14 |
9 |
p. 4001-4013 |
artikel |
24 |
PEGylated bacteria restore intestinal mucosal barrier
|
Zu, Menghang |
|
|
14 |
9 |
p. 4186-4188 |
artikel |
25 |
Recent advances to address challenges in extracellular vesicle-based applications for lung cancer
|
Huang, Gaigai |
|
|
14 |
9 |
p. 3855-3875 |
artikel |
26 |
SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites
|
Zhu, Kaixiang |
|
|
14 |
9 |
p. 4164-4173 |
artikel |
27 |
Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism
|
Li, Bin |
|
|
14 |
9 |
p. 3949-3963 |
artikel |
28 |
Table of Contents
|
|
|
|
14 |
9 |
p. iii-xii |
artikel |
29 |
Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation
|
Zheng, Yaxian |
|
|
14 |
9 |
p. 3876-3900 |
artikel |
30 |
Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption
|
Yan, Mengyi |
|
|
14 |
9 |
p. 4118-4133 |
artikel |
31 |
Triple three-dimensional MS/MS spectrum facilitates quantitative ginsenosides-targeted sub-metabolome characterization in notoginseng
|
Zhang, Ke |
|
|
14 |
9 |
p. 4045-4058 |
artikel |
32 |
Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment
|
Kao, Aaron T. |
|
|
14 |
9 |
p. 3785-3801 |
artikel |